Just after the close of regular trading, Edwards Lifesciences released fourth quarter and full year 2025 financial results. During today's call, management will discuss the results included in the ...
While I'll continue on to my role as Upstart's Executive Chairman. As I said in the press announcement, Paul and I have been ...
Record Revenues of $4.5 billion in 2025, including a record $1.28 billion in Q4Record Diluted EPS of $2.05 in 2025, including $0.66 in Q4Record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results